| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRDM | Common Stock | Options Exercise | $754K | +32.6K | +44.25% | $23.15 | 106K | Jul 28, 2021 | Direct | |
| transaction | IRDM | Common Stock | Sale | -$1.33M | -32.6K | -30.68% | $40.89 | 73.6K | Jul 28, 2021 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IRDM | Employee Stock Option (Right to Buy) | Options Exercise | $0 | -32.6K | -48.44% | $0.00 | 34.7K | Jul 28, 2021 | Common Stock | 32.6K | $23.15 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.74 to $41.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| F2 | 25% of the shares underlying the option vested and became exercisable on March 1, 2020 and the remaining shares underlying the option vest and become exercisable quarterly thereafter in equal installments on June 1, September 1 and December 1 so that all shares of common stock underlying the option shall vest and become exercisable on March 1, 2023. |